Sigachi Industries Ltd Q1 FY27 Earnings Analysis

Published 7 Jun 2026 | Pharmaceuticals & Biotechnology | Market Cap: ₹774 Cr

Price

21.5

Market Cap

₹774 Cr

P/E Ratio

19.3

Revenue Rank

Rank 2

Margin Rank

Rank 1

Earnings Summary

- Sigachi expects revenue for FY27 in the range of INR 650-675 crores, supported by incremental capacities from Dahej and Jhagadia and an improved product mix. - FY27 revenue guidance: INR 650-675 crores with EBITDA margin of 18-20%, improved from current margins (~7%) - Utilization and margins expected to normalize by FY27 to mid-FY28, with margins reachi

📊 Revenue & Sales Performance

Rank 2

- Sigachi expects revenue for FY27 in the range of INR 650-675 crores, supported by incremental capacities from Dahej and Jhagadia and an improved product mix. - Expansion includes 12,000 metric tons capacity increase at Dahej H2 with CapEx of INR 106 crores, plus new CCS capacity (~INR 90 crores CapEx) expected to commercialize by Q1 FY28. - Full capacity including MCC and CCS is expected to boost revenues significantly beyond FY27; the company targets INR 1000 crores turnover by around FY29. - Volume growth expected from capacity expansion (from current 18,000 metric tons plus an additional 12,000 metric tons). - API segment revenue is projected to increase from 14% to about 18-20% of total revenue, adding to topline growth. - Utilization rates for MCC are anticipated to increase from current 75-80% to north of 90% in FY27, enhancing output. - New CCS product commands higher margins and pricing, expected to contribute meaningfully post-launch.

📈 Profitability & Margins

Rank 1

- FY27 revenue guidance: INR 650-675 crores with EBITDA margin of 18-20%, improved from current margins (~7%) - Utilization and margins expected to normalize by FY27 to mid-FY28, with margins reaching 15-20% range - MCC utilization currently ~75-80%, expected to increase to 90-95% progressively post-accident safety stabilization - Incremental capacity of 12,000 MT (Dahej H2) expected by end-FY27, contributing significant revenue and EBITDA growth - API segment expected to grow from INR 60 crores currently to over INR 100 crores next year - CCS product commercialization targeted by Q1 FY28, with margins higher than 20% (CCS priced 2-3x MCC) - Long-term revenue target of INR 1000 crores expected around FY29 (not by FY28) - Management expects gradual debt reduction and return to higher profitability supported by expanded capacities and improved product mix

🏗️ Capital Expenditure Plans

Yes

- Ongoing CapEx for expanding MCC capacity by 12,000 metric tons at Dahej H2 with a cost of around INR 106 crores. - CapEx for CCS project totaling around INR 90 crores, expected to commercialize by Q1 FY28. - Dahej has 20 acres of land and Kurnool has 25 acres available for future capacity expansions. - Plans to gradually increase capacities based on market demand, targeting 50,000-70,000 metric tons in the coming years. - Funding for CapEx will be a combination of internal accruals, term loans, and possible equity fundraising; plans are under discussion. - No finalized fund-raising structure announced yet, details to be disclosed in due course.

💰 Fundraising & Capital Structure

Yes

- The company is considering funding its CapEx through a combination of internal accruals, term loans (debt), and possibly fresh equity fundraising. - The exact mix of equity and debt fundraising is still under discussion and is described as being in a fluid stage. - Management will announce the fundraising plans once they are finalized and appropriate resolutions are passed. - Current debt primarily comprises working capital, with no long-term debt outstanding. - Future fundraising decisions will be made based on need, market conditions, and internal assessments.

📋 Order Book & Pipeline

No information

- The company mentioned ongoing business talks and some clients already lined up supporting revenue growth. - Expected revenue from the new 12,000 metric tons capacity expansion is around INR 200-220 crores. - From the Contract Custom Synthesis (CCS) segment, approximately INR 100 crores of revenue is anticipated. - Demand for CCS is good, with inquiries and customers requesting dispatches alongside MCC, indicating a healthy order pipeline. - Current focus is on gradually increasing MCC utilization from 75-80% to 90-95% during the year. - Overall, Sigachi expects to achieve a top-line of INR 650-675 crores for FY27 supported by expanded capacities, API growth, and new business from CCS. - The management indicated expansion plans are ongoing as long as market demand persists, with decisions on future CapEx and orderbook updates forthcoming.

Key Metrics

Revenue

Rank 2

Margin

Rank 1

Capex

Yes

Fundraise

Yes

Order Book

No information

Frequently Asked Questions

What were Sigachi Industries Ltd Q1 FY27 results?

- Sigachi expects revenue for FY27 in the range of INR 650-675 crores, supported by incremental capacities from Dahej and Jhagadia and an improved product mix. - FY27 revenue guidance: INR 650-675 crores with EBITDA margin of 18-20%, improved from current margins (~7%) - Utilization and margins expected to normalize by FY27 to mid-FY28, with margins reachi

What is Sigachi Industries Ltd share price analysis?

Sigachi Industries Ltd currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 19.3 with a market cap of ₹774. Investors should review the full earnings analysis for detailed insights.

Is Sigachi Industries Ltd planning capital expenditure?

- Ongoing CapEx for expanding MCC capacity by 12,000 metric tons at Dahej H2 with a cost of around INR 106 crores.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.